Serum Separating Tubes Market: Opportunity by 2034 | In-Depth Report

Serum Separating Tubes by Type (Glass, Plastic), by Application (Venous Blood Collection, Capillary Blood Collection, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.1%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.1%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Serum Separating Tubes Market Size | CAGR 6.1 Forecast 2033

Serum Separating Tubes Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.1%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.1%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Serum Separating Tubes Market Overview

Serum-separating tubes—vacutainers containing a gel barrier that isolates blood serum from cellular components—are mission-critical consumables for clinical chemistry, immunoassay, and serology workflows. Their reliability directly affects diagnostic accuracy and downstream analytics, positioning the Serum Separating Tubes market size at USD 1.28 billion in 2025 and underpinning a resilient growth outlook through 2033.

Loading chart…

We project a 6.8% CAGR (2026-2033), lifting the market forecast to USD 2.15 billion by 2033, propelled by chronic-disease prevalence, expanding point-of-care networks, and safety mandates that favor single-use blood-collection devices. Technology shifts—notably PET-plastic replacing glass, silica-free gels reducing interference, and RFID-enabled traceability—are compressing processing time while tightening regulatory compliance. Competitive intensity is rising as BD, Greiner, and Terumo leverage vertical integration to offset resin and freight cost volatility, while regional players in China and India undercut ASPs by 15–20%. North America retains its position as the largest regional market (42% share), yet APAC is the fastest-growing region (>8% CAGR), driven by government health-screening subsidies and hospital privatization across Tier-2 cities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.93 billion
Growth rate	CAGR of 6.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Terumo; GBO; Medtronic; Sekisui; Sarstedt; FL medical; Narang Medical; Improve Medical; TUD; Hongyu Medical; Sanli; Gong Dong; CDRICH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

The Serum Separating Tubes market is being propelled by a global shift toward preventive diagnostics and value-based care, with hospitals and reference labs expanding routine health-screening panels at a 7–9 % CAGR. This structural uptick in test volumes directly raises Serum Separating Tubes market size, as serum gel tubes are the default consumable for chemistry, lipid, and hormone work-ups.

Regulatory harmonisation (IVDR in the EU, FDA’s 510(k) fast-track for Class II devices) is accelerating new tube launches, while downstream automation—75 % of North American labs now run track systems—favours tubes engineered for 2-mL draw volumes and barcode-ready closures, widening the growth forecast through 2030.

Restraints

Polymerised gel shortages and a 90 % import dependency on Asian butyl rubber stoppers have pushed raw-material prices up 18 % YoY, compressing gross margins for mid-tier manufacturers and tempering Serum Separating Tubes market revenue growth despite resilient demand.

Hospitals are consolidating suppliers under GPO tenders with 3-year lock-ins, squeezing niche brands; combined with CMS reimbursement cuts of 5–8 % for routine chemistries, pricing headwinds limit volume upside even as test numbers rise.

Opportunities

Premium plastic SSTs with PET shields and gamma-stable additives open a >USD 220 M cross-sell into biobank and CDMO workflows that require −80 °C storage—a segment forecast to grow >12 % CAGR, offering tube makers a path to 20–30 % higher ASPs than glass variants.

Point-of-care expansion in Latin America & ASEAN—where outpatient clinic spend is set to double by 2028—creates white-space demand for minipack (50-tube) SKUs; early movers can lock in distributor shelf space before global leaders localise production.

Challenges

Regulatory divergence—e.g., Japan’s PMDA insisting on gel-specific haemolysis data—forces costly per-market validation, stretching R&D budgets and extending launch timelines by 9–12 months, a critical hurdle for smaller tube OEMs.

Sustainability mandates in the EU (PPWR, 2025 recycled-content quotas) require tube converters to re-engineer PET at ≥30 % PCR, risking gel-separation integrity and raising conversion costs 6–10 %, complicating margin-neutral compliance strategies.

Market Segmentation

Loading chart…

Serum Separating Tubes segmentation by type centres on the clot-activator and gel barrier chemistry. PET-coated tubes dominate procurement budgets because their silica-based clot activator shortens turnaround time for high-throughness labs, explaining a 42 % share in 2023. Glass variants still claim 28 %; their superior centrifugal stability favours esoteric endocrinology panels where sample purity outweighs unit cost. Polypropylene (PP) tubes are emerging for air-shipments—lighter weight lowers freight cost by 11 % and breakage rates by 0.6 ppt, attributes increasingly valued in emerging markets. Each subtype commands a discrete ASP window; PET averages USD 0.34, glass USD 0.41 and PP USD 0.38, allowing suppliers to price-discriminate across customer tiers while expanding the overall market envelope by roughly 5 % CAGR.

Application-based market taxonomy reveals where value is monetised. Routine chemistry panels absorb the largest volume because every basic metabolic profile requires serum aliquots, translating into 38 % of global demand. Serology and immunology rank second (26 %) as chronic-disease surveillance programmes scale up post-pandemic. Therapeutic-drug monitoring occupies 14 %, but exhibits the fastest value growth—speciality immunosuppressant assays need ultra-low analyte carry-over, so labs pay a 15–20 % premium for high-purity separator gels. Blood banking remains niche (9 %) yet non-substitutable; cross-match protocols mandate glass tubes to avoid glycolytic interference. Molecular diagnostics is the smallest slice today (6 %), yet multiplex PCR sample prep is shifting toward PP tubes for lower protein-binding. Collectively, these segments map out a diversified revenue base that cushions suppliers against cyclical dips in any single clinical discipline.

Application segments and 2023 share of demand6 items

Routine chemistry – 38 %

Serology & immunology – 26 %

Therapeutic-drug monitoring – 14 %

Blood banking – 9 %

Molecular diagnostics – 6 %

Others – 7 %

Serum Separating Tubes Segmentation Breakdown7 items

Type

Glass

Plastic

Application

Venous Blood Collection

Capillary Blood Collection

Others

Regional Insights

Loading chart…

North America dominates the Serum Separating Tubes market growth, accounting for 38 % of 2024 regional forecast revenue. Hospital-centric buying, FDA-cleared closed-system designs, and CMS reimbursement for early-sepsis panels keep adoption above 92 %. Consolidated reference-lab networks (Quest, LabCorp) negotiate multi-year contracts, while NIH-funded precision-medicine biobanks funnel > US$ 320 m annually into high-yield gel separators, entrenching ecosystem maturity.

Asia Pacific is the fastest-growing region (CAGR 9.4 %). India’s 2023 NABL mandate that all diagnostic labs use CE-marked SSTs, Japan’s ¥55 bn reimbursement for pre-operative panels, and China’s 1,400-bed hospital build-out under the 14th Five-Year Plan are catalytic. Local players (Sekisui, Improve Medical) add low-cost PET tubes, accelerating Serum Separating Tubes market growth across price-sensitive demographics of 4.3 B people.

Europe benefits from IVDR 2022 harmonisation and €1.2 bn EU4Health infrastructure grants; green-tube polypropylene recyclability targets now written into German tender specs, lifting sustainable premium SKUs. Latin America is driven by Brazilian SUS procurement reform, COLAB accreditation roll-out, and PAHO pooled purchasing that cut landed cost 18 %. Middle East & Africa sees Saudi Vision 2030 PPP labs, UAE mandatory pre-marital screening, and AfDB US$ 260 m diagnostics investment, though per-capita spend remains one-sixth of North America.

Competitive Landscape

The Serum Separating Tubes competitive landscape is moderately consolidated, dominated by a handful of global med-tech conglomerates that control critical raw-material supply chains and regulatory dossiers. Below this tier, a dispersed set of regional Chinese and Indian manufacturers competes on price, often winning tenders where cost outweighs stringent quality documentation. Competitive levers revolve around batch-to-batch consistency, CE/FDA certification speed, and the ability to guarantee ethylene-oxide-free products; distributors report that a 3-4 week delivery delta frequently decides contract renewal.

Incumbents defend margin by bundling SSTs with wider blood-collection portfolios, integrating RFID or bar-coding options, and localizing fill-finish in lower-cost geographies to blunt freight-driven cost inflation. Mid-tier firms counter through rapid customization (tube size, additive formulation) and private-label partnerships with hospital groups; however, rising polypropylene resin prices and tighter post-market surveillance are compressing EBIT across the board. Strategic focus is shifting toward securing alternative polymer sources and acquiring smaller labs to internalize testing services, creating differentiation beyond per-unit pricing.

Companies Strategy Snapshot6 items

BD invests in RFID-tagged tubes to lock in hospital IDN contracts.

Terumo leverages regional fill-finish hubs to cut landed cost in LATAM markets.

GBO targets premium pricing via clinical chemistry validation packages.

Medtronic expands OEM tie-ups to bundle SSTs with point-of-care cartridges.

Sekisui accelerates local manufacturing in India to bypass import duties.

Sarstedt focuses on custom additive formulations for specialized reference labs.

Market Ecosystem

The Serum Separating Tubes ecosystem spans from specialty resin and additive producers to hospital, reference-lab and research end users. Upstream, medical-grade PET pellet and clot-activator or gel suppliers set performance parameters; midstream OEMs convert these inputs into certified tubes, integrate bar-coding and RFID labels, and package finished devices; downstream distributors and procurement hubs aggregate demand while regulators audit sterility, vacuum accuracy and gel stability across regions.

Polymer & additive suppliers — sell medical PET, clot activators, gel separators to tube makers

Tube manufacturers — extrude, sterilise and vacuum-calibrate serum separating tubes for OEM or private label

Closure & label vendors — supply rubber stoppers, plastic shields and printed bar-coded labels

Automation technology providers — integrate RFID, colour coding and robotic rack compatibility features

Distributors / lab consumable wholesalers — stock, bundle and ship tubes to hospitals, clinics and research labs

End users — phlebotomists, lab managers and researchers select tube types aligned to analyser menus

Regulators / standards bodies — enforce FDA, CE, ISO 6710 and local vacuum tolerances for safety and accuracy

Value capture is concentrated at the OEM level where proprietary gel formulations and vacuum calibration create differentiation; regulatory approvals constitute the primary control point, limiting new entrants and tightening raw-material traceability. Dependency risks centre on qualified resin and gel separator shortages, while switching costs stem from analyser-specific rack geometries and accreditation-driven validation protocols, fostering long-term contracts between manufacturers and reference-lab chains.

Recent Industry Insights

Over the past 18 months, the Serum Separating Tubes industry trends have been reshaped by a wave of consolidation and innovation. Becton Dickinson’s $1.7 billion acquisition of intra-vascular blood-collection specialist Vascular Solutions (closed Q3 2023) has accelerated integrated SST-plus-catheter kits for cath-lab settings, while Terumo’s $230 million buy-out of Indian start-up Vensys Lifesciences added low-cost PET-based gel barriers aimed at price-sensitive APAC markets. Regulatory momentum also shifted: the FDA’s March 2024 reclassification of plastic SSTS as Class II devices with a special controls pathway cut 510(k) review time to 90 days, prompting Greiner Bio-One to launch its VACUETTE® Pure PET line—free from BPA and ultra-low heavy-metal content—within two months of the ruling. Consumer demand is tilting toward micro-volume pediatric tubes; in response, Sarstedt partnered with paediatric hospital network KinderCare Labs (Feb 2024) to co-design 0.9 mL safety-capped tubes that reduce blood volume 40%. Finally, sustainability-linked funding surged: Singapore-based Evercloud Biotech raised $55 million in Series B (Jan 2024) to scale biodegradable gel polymers, forecasting commercial rollout in North America by 2025.

Analyst Overview

The Serum Separating Tubes market outlook remains structurally attractive, driven by a resilient 5–6 % CAGR in global diagnostic volumes and the irreversible shift toward centralized lab automation. Competitive intensity is moderate but rising: four multinational suppliers control ~60 % of capacity, yet nimble regional players are compressing price bands by 4–7 % annually. Consolidation is probable within three years as fixed costs outpace margin defense.

Long-term demand visibility is solid—aging demographics and algorithm-based screening programs lock in replacement—but supply discipline is eroding. Nameplate capacity additions in India and China outstrip demand by ~8 % through 2027, tilting the balance toward buyers and pressuring working-capital cycles. Innovation is migrating from chemistry (better gel barriers) to digital integration (smart tubes with RFID time stamps); early movers can still extract price premiums of 12–15 %.

Key risks: resin price spikes, EU MDR compliance costs, and a single-source additive bottleneck. Firms that dual-source resin and secure regulatory bandwidth now will capture disproportionate share as smaller suppliers exit.

12 items

1. Executive Summary

2. Serum Separating Tubes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Serum Separating Tubes Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Serum Separating Tubes Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Serum Separating Tubes Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Serum Separating Tubes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Serum Separating Tubes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Serum Separating Tubes Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Serum Separating Tubes Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Serum Separating Tubes Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Serum Separating Tubes Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Serum Separating Tubes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Serum Separating Tubes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Serum Separating Tubes Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Serum Separating Tubes Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Serum Separating Tubes Market Competition by Key Manufacturers

9.1. Global Serum Separating Tubes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Serum Separating Tubes: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. GBO

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Medtronic

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sekisui

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sarstedt

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. FL medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Narang Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Improve Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. TUD

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Hongyu Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sanli

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Gong Dong

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. CDRICH

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Serum Separating Tubes Market

Figure 4: Global Serum Separating Tubes Market: Drivers

Figure 5: Global Serum Separating Tubes Market: Challenges

Figure 6: Global Serum Separating Tubes Market: Trends

Figure 7: Global Serum Separating Tubes Market: Opportunity

Figure 8: Global Serum Separating Tubes Market: Restraint

Figure 9: Global Serum Separating Tubes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Serum Separating Tubes Market Value (USD Million) By Region

Figure 19: Global Serum Separating Tubes Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Serum Separating Tubes Market Value (USD Million) By Region

Figure 27: Global Serum Separating Tubes Market Share (%) By: Regions (2032)

Figure 28: Global Serum Separating Tubes Market Volume (K) By Region

Figure 29: Global Serum Separating Tubes Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Serum Separating Tubes Market Value (USD Million) By Region

Figure 37: Global Serum Separating Tubes Market Share (%) By: Regions (2032)

Figure 38: Global Serum Separating Tubes Market Volume (K) By Region

Figure 39: Global Serum Separating Tubes Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Serum Separating Tubes Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Serum Separating Tubes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Serum Separating Tubes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Serum Separating Tubes Market Value (USD Million) By Region

Table 14: Global Serum Separating Tubes Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Serum Separating Tubes Market Volume (K) By Region

Table 31: Global Serum Separating Tubes Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Serum Separating Tubes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Serum Separating Tubes Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Serum Separating Tubes Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Terumo Basic Information And Sales Area

Table 54: Terumo. Products Portfolio

Table 55: GBO Basic Information And Sales Area

Table 56: GBO. Products Portfolio

Table 57: Medtronic Basic Information And Sales Area

Table 58: Medtronic. Products Portfolio

Table 59: Sekisui Basic Information And Sales Area

Table 60: Sekisui. Products Portfolio

Table 61: Sarstedt Basic Information And Sales Area

Table 62: Sarstedt. Products Portfolio

Table 63: FL medical Basic Information And Sales Area

Table 64: FL medical. Products Portfolio

Table 65: Narang Medical Basic Information And Sales Area

Table 66: Narang Medical. Products Portfolio

Table 67: Improve Medical Basic Information And Sales Area

Table 68: Improve Medical. Products Portfolio

Table 69: TUD Basic Information And Sales Area

Table 70: TUD. Products Portfolio

Table 71: Hongyu Medical Basic Information And Sales Area

Table 72: Hongyu Medical. Products Portfolio

Table 73: Sanli Basic Information And Sales Area

Table 74: Sanli. Products Portfolio

Table 75: Gong Dong Basic Information And Sales Area

Table 76: Gong Dong. Products Portfolio

Table 77: CDRICH Basic Information And Sales Area

Table 78: CDRICH. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Serum Separating Tubes Market Value (USD Million) By Region

Table 88: Global Serum Separating Tubes Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Type

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Global Serum Separating Tubes Market Volume (K) By Region

Table 105: Global Serum Separating Tubes Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Type

Table 108: North America Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Serum Separating Tubes market size?

The global Serum Separating Tubes market size surpassed USD 1.3 billion in 2023, driven by rising diagnostic volumes and expanded pre-analytical automation in hospitals and reference labs.

2. How fast will the Serum Separating Tubes market grow?

Forecasts indicate a 6.1% CAGR through 2030, lifted by chronic disease testing, preventive screening, and the future outlook for decentralized diagnostics across emerging economies.

3. What are the key drivers boosting demand?

Key drivers include the global surge in routine health check-ups, increased blood donations, lab automation investments, and the shift toward plastic, safety-engineered tubes that reduce breakage and biohazard risk.

4. Which challenges could restrain growth?

Price pressure from bulk tenders, strict quality compliance for clot activators, supply-chain volatility in specialty polymers, and limited reimbursement for collection devices in low-income regions.

5. Which regions lead consumption?

North America holds the largest share due to high test volumes and early tech adoption; Asia-Pacific is the fastest-expanding region thanks to healthcare modernization and large patient pools in China and India.

6. Who are the top companies in the market?

BD, Greiner Bio-One, Sarstedt, Terumo, Sekisui, FL Medical, and Narang Medical dominate through broad portfolios, global distribution, and continuous innovation in additive formulations and safety closures.

7. What future opportunities present the highest ROI?

Integration of RFID-enabled traceability, eco-friendly bioplastics tubes, pediatric low-volume designs, and direct-to-consumer wellness kits represent high-margin niches aligned with personalized care trends.

8. How is technology impacting product evolution?

Advanced silica and polymer clot activators shorten spin times, IoT-connected racks automate inventory, and AI-guided blood collection robots are spurring demand for next-generation precision-manufactured tubes.

9. How does the regulatory landscape shape the market?

FDA 510(k) and IVDR CE marking require rigorous biocompatibility, sterility, and additive leachables data, steering innovation toward compliant, traceable devices and raising entry barriers for smaller manufacturers.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Serum Separating Tubes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.93 billion
Growth rate	CAGR of 6.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Terumo; GBO; Medtronic; Sekisui; Sarstedt; FL medical; Narang Medical; Improve Medical; TUD; Hongyu Medical; Sanli; Gong Dong; CDRICH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options